Ligand field and polarity tuning of Fe( ii ) complexes for selective ROS-mediated anticancer activity
Authors:
- 10 April 2026
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 62 (33) , 8491-8495
Abstract
A redesigned N5-type ligand that strengthens the donating ability while reducing polarity was utilized to generate an Fe( ii ) complex.Keywords
Funding Information
- National Research Foundation of Korea (2021R1A6A1A10039823)
- National Research Foundation of Korea (RS-2025- 20942968)
- National Research Foundation of Korea (RS-2026-25485867)
- National Research Foundation of Korea (RS-2024- 00414215)
- Shiv Nadar University
This publication has 32 references indexed in Scilit:
- Interplay of oxidative stress and antioxidant mechanisms in cancer development and progressionArchives of Toxicology, 2025
- Mitochondrial dysfunction and aging: multidimensional mechanisms and therapeutic strategiesBiogerontology, 2025
- Transition Metal Catalysis in Living Cells: Progress, Challenges, and Novel Supramolecular SolutionsAngewandte Chemie International Edition, 2023
- What is cancer metabolism?Cell, 2023
- Redox metabolism: ROS as specific molecular regulators of cell signaling and functionMolecular Cell, 2021
- Oxidative Stress in CancerCancer Cell, 2020
- Caspases in Cell Death, Inflammation, and DiseaseImmunity, 2019
- Review of iron-free Fenton-like systems for activating H2O2 in advanced oxidation processesJournal of Hazardous Materials, 2014
- Oxidative damage, ageing, and life-history evolution: where now?Trends in Ecology & Evolution, 2012
- Atom/Fragment Contribution Method for Estimating Octanol–Water Partition CoefficientsJournal of Pharmaceutical Sciences, 1995